drugset / Trial / NCT01960140
A Study of Baricitinib and Simvastatin in Healthy Participants
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purposes of this study are to determine the effects of baricitinib on the time it takes to remove simvastatin from the body and to look at how well-tolerated and safe baricitinib is when given alone and in combination with simvastatin. Side effects will be documented. The study will last approximately 7 days from the first dose to the end of the study (not including screening or follow-up).
Timeline
- Start
- 2013-10
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baricitinib | Small molecule | 10 mg | Oral |
| Subject | Simvastatin | Small molecule | 40 mg | Oral |
Indications
No indication recorded.